CervoMed Inc (CRVO) Stock Price, Quote, News & History

CRVONASDAQ
$3.07
-0.02-0.65%
At close: Aug 12, 5:00 PM EST
$3.04
-0.03-0.98%
After Hours: 7:46 PM EST
Earnings: Q2 2026 Earnings were released on Mon Aug 10th, before the market open

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-27.98M
Investing Cash Flow (TTM)
23.19M
Financing Cash Flow (TTM)
18.93M
Free Cash Flow (TTM)
-27.98M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
14.14M

Analyst Trends and Forecast

1
Feb
6
Mar
3
Apr
3
Jul
2
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$16.18M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.79
Earnings Yield % (TTM)
-105.59%
Earnings Yield % (FWD)
-84.54%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.70

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$22.46M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$3.07
Close
$3.07
Volume / Avg.
237.78K / 5.50M
Day Range
$3.01 - $3.14
52 Wk Range
2.13 - 11.25
Market Cap
$28.15M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
13.08%
Days to Cover
2.72

About

Sector
Health Care
Industry
Biotechnology
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the rever...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy CervoMed (CRVO) stock?

A

You can purchase shares of CervoMed (NASDAQ:CRVO) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for CervoMed (CRVO) stock?

A

CervoMed has a consensus price target of $26.56.

Q

What is the current price for CervoMed (CRVO)?

A

The stock price for CervoMed (NASDAQ: CRVO) is $3.04 last updated August 12, 2026 at 7:46 PM EDT.

Q

Does CervoMed (CRVO) pay a dividend?

A

There are no upcoming dividends for CervoMed.

Q

When is CervoMed (NASDAQ:CRVO) reporting earnings?

A

CervoMed does not have any upcoming earnings scheduled.

Q

Is CervoMed (CRVO) going to split?

A

There is no upcoming split for CervoMed.

Q

What sector and industry does CervoMed (CRVO) operate in?

A

CervoMed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.